Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation (RAPID GENE)

This study has been completed.
Spartan Bioscience Inc.
Information provided by (Responsible Party):
Ottawa Heart Institute Research Corporation Identifier:
First received: August 17, 2010
Last updated: November 10, 2011
Last verified: November 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2011
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):